The Oregon Renaissance Faire is an annual event that celebrates the art, culture and spirit of the Renaissance period over three themed weekends in June. Set in the Vale of Dunrose, a recreated Scottish village, the Faire invites visitors to immerse themselves in the magic and splendor of the era. With live entertainment, artisan crafts, delicious food and interactive experiences, the Faire promises an unforgettable journey into the past for guests of all ages. For more information, visit oregonfaire.com.

DATES: Saturday & Sunday, June 1 – 2, 8 – 10, & 15 – 16, 2024, 10 a.m. – 7 p.m.

+ new Friday Night Concerts, May 31, June 7, and June 14, 6 p.m. – 12 a.m.

LOCATION: Canby, OR at the Clackamas County Fairgrounds

INFO & TICKETS: Visit www.oregonfaire.com

Canby, Oregon (April 2, 2024) – The Oregon Renaissance Faire invites one and all to step back in time and experience the enchanting world of the Renaissance era. Set in the picturesque Vale of Dunrose, the Faire offers three weekends of history, fantasy, and fun for the entire family. This year, the Faire will be held on the first three weekends of June, promising even more magic and merriment than ever before.

Visitors will be transported to a time where knights, jesters and royalty roam the streets. With an array of live performances, including jousting tournaments, music, dance, and theater, visitors will be captivated throughout the day.

The Faire offers a wide array of activities and experiences to entertain and educate guests of all ages. Children can take part in hands-on workshops, learning historical crafts like candle-making and blacksmithing, while adults can enjoy mead and ale tastings while appreciating Renaissance art, music and lifestyles. With interactive games, such as archery, axe throwing and boffering, there is no shortage of fun and excitement for everyone.

The 2024 Oregon Renaissance Faire also hosts an extensive marketplace, featuring over 100 artisan vendors selling unique, handcrafted wares for the perfect souvenir or gift — from intricate jewelry and fine leather goods to one-of-a-kind clothing and unique pottery.

Each weekend of the Faire features a special theme, adding an extra layer of excitement to the festivities. From Celtic celebrations to fantasy adventures, there’s something for everyone to enjoy.

NEW for this year, the Faire will host special Friday night concerts, and back by popular demand are the Saturday after-hours themed parties, extending the fun into the night.

“We’re thrilled to bring the Oregon Renaissance Faire back for the 7th Season,” said Shana Casey, Marketing Director. “It’s a chance to escape the modern world and immerse yourself in the sights, sounds, and tastes of the Renaissance. We can’t wait to welcome both returning patrons and first-time visitors to this year’s event.”

Tickets are available online only at oregonfaire.com. For more information about the Faire, including a schedule of events and details about each themed weekend, please visit their website, oregonfaire.com or follow them on social media.

Don’t miss this opportunity to experience the magic of the Renaissance era. Join the Oregon Renaissance Faire for a journey back in time that you’ll never forget!

The Oregon Renaissance Faire is put on by The Washington Renaissance Arts & Education Society (WRAES). WRAES was formed in 2006 as a 501 (c)3 nonprofit organization. Their mission is to educate and entertain the public through performance, sale of wares and demonstrations of the Renaissance and other similar time periods. Their work introduces children and adults to the rich history of our ancestors so that after they light the spark, they will continue to look for other avenues to learn more about this exciting time in history.

Sotheby’s Concierge Auctions, which found a buyer for the Blackberry Castle estate in Northwest Portland and actor Patrick Duffy’s Rogue River property in southern Oregon’s Eagle Point last year, has a new offering: Nastucca Sea Ranch overlooking the Pacific Ocean in the unincorporated Oregon coastal community of Cloverdale.

The almost 26-acre Nastucca Sea Ranch at 41900 Horizon View Ave. is listed for $10 million by broker Brian Ladd of Cascade Hasson Sotheby’s International Realty. But while the bidding window is open through May 16, there is no minimum required for the secluded property with views of the ocean, Nestucca River and bay.

PORTLAND, Ore. – Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.

In cell culture and mouse models, scientists in the OSU College of Pharmacy demonstrated a novel technique for the aerosolization of inhalable nanoparticles that can be used to carry messenger RNA, the technology underpinning COVID-19 vaccines, to patients’ lungs.

The findings are important because the current nebulization method for nanoparticles subjects them to shear stress, hindering their ability to encapsulate the genetic material and causing them to aggregate in certain areas of the lungs rather than spread out evenly, the researchers said.

The study led by Gaurav Sahay, a professor of pharmaceutical sciences, was published in ACS Nano.

Sahay’s lab studies lipid nanoparticles, or LNPs, as a gene delivery vehicle with a focus on cystic fibrosis, a progressive genetic disorder that results in persistent lung infection and affects 30,000 people in the U.S., with about 1,000 new cases identified every year.

One faulty gene – the cystic fibrosis transmembrane conductance regulator, or CFTR – causes the disease, which is characterized by lung dehydration and mucus buildup that blocks the airway.

Lipids are organic compounds containing fatty tails and are found in many natural oils and waxes, and nanoparticles are tiny pieces of material ranging in size from one- to 100-billionths of a meter. Messenger RNA delivers instructions to cells for making a particular protein.

With the coronavirus vaccines, the mRNA carried by the lipid nanoparticles instructs cells to make a harmless piece of the virus’ spike protein, which triggers an immune response from the body. As a therapy for cystic fibrosis, the genetic material would fix the flaw in patients’ CFTR gene.

“We utilized a novel microfluidic chip that helps in generation of plumes that carry nanoparticles and does not cause any shear stress,” Sahay said. “This device is based on the similar idea of an ink-jet cartridge that generates plumes to print words on paper.”

Four years ago, Sahay said, an Oregon-based startup called Rare Air Health Inc. contacted him about the prospect of using microfluidic technology for the aerosolization and delivery of lipid nanoparticles.

Microfluidics is the study of how fluids behave as they travel through or are confined in microminiaturized devices equipped with channels and chambers. Surface forces as opposed to volumetric forces dominate fluids at the microscale, meaning fluids act much differently there than what is observed in everyday life.

“When Rare Air came to me, I thought the device might work great for our purposes, and what followed were extensive studies that demonstrated the superiority of this device in generating aerosolized nanoparticles as compared to clinically used vibrating mesh nebulizers,” Sahay said. “The device does not let the nanoparticles aggregate and can deliver mRNA with higher precision than existing tech. The additional cool thing is that this device can be digitally controlled, and Rare Air is developing prototypes for human use.”

In addition to Sahay, the other Oregon State researchers on the study were Yulia Eygeris, Jeonghwan Kim, Antony Jozić and Elissa Bloom. Scientists from Funai Microfluidic Systems of Lexington, Kentucky, were also part of the collaboration.

“Funai focuses on inkjet tech and building these chips at scale; they worked closely to enable the device to be suitable for aerosolization,” said Sahay, who in addition to his role at OSU serves as an advisor and consultant to Rare Air. “This study demonstrates a marriage between new devices and formulation science that might hugely impact human health.”

Funding from the National Heart, Lung, and Blood Institute and Rare Air supported the study.